Market capitalization of PhaseBio Pharmaceuticals (PHAS)

Last known market cap: £2.62 Million

On January 5, 2023 PhaseBio Pharmaceuticals had a market cap of £2.62 Million. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PhaseBio Pharmaceuticals from 2018 to 2023

End of year Market Cap

Year	Marketcap	Change
2023	£2.74 M	-5.04%
2022	£2.88 M	-96.89%
2021	£92.98 M	28.46%
2020	£72.38 M	-46%
2019	£0.13 B	124.76%
2018	£59.63 M

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
ORIC Pharmaceuticals ORIC	£0.74 B	28,117.74%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions